Skip to main content
 

21 CFR 26, Subpart A, Appendix E to Subpart A of Part 26 - Elements To Be Considered in Developing a Two-Way Alert System

prev | next
Pt. 26, Subpt. A, App. E
Appendix E to Subpart A of Part 26—Elements To Be Considered in Developing a Two-Way Alert System
1. Documentation
—Definition of a crisis/emergency and under what circumstances an alert is required
—Standard Operating Procedures (SOP's)
—Mechanism of health hazards evaluation and classification
—Language of communication and transmission of information
2. Crisis Management System
—Crisis analysis and communication mechanisms
—Establishment of contact points
—Reporting mechanisms
3. Enforcement Procedures
—Followup mechanisms
—Corrective action procedures
4. Quality Assurance System
—Pharmacovigilance programme
—Surveillance/monitoring of implementation of corrective action
5. Contact Points
For the purpose of subpart A of this part, the contact points for the alert system will be:
A. For the European Community:
the Executive Director of the European Agency for the Evaluation of Medicinal Products, 7, Westferry Circus, Canary Wharf, UK - London E14 4HB, England. Telephone 44-171-418 8400, Fax 418-8416.
B. For the United States :
Biologics: Director, Office of Compliance and Biologics Quality (HFM-600), 1401 Rockville Pike, Rockville, MD 20852, phone: 301-827-6190, fax: 301-594-1944.
Human Drugs: Director, Office of Compliance, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, phone: 301-796-3100, fax: 301-847-8747.
Veterinary Drugs: Director, Office of Surveillance and Compliance (HFV-200), MPN II, 7500 Standish Pl., Rockville, MD 20855-2773, phone: 301-827-6644, fax: 301-594-1807.
[63 FR 60141, Nov. 6, 1998, as amended at 69 FR 48775, Aug. 11, 2004; 74 FR 13112, Mar. 26, 2009]

Title 21 published on 2012-04-01

no entries appear in the Federal Register after this date.

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.


United States Code
USC : Title 5 - GOVERNMENT ORGANIZATION AND EMPLOYEES

§ 552 - Public information; agency rules, opinions, orders, records, and proceedings

USC : Title 15 - COMMERCE AND TRADE

§ 1453 - Requirements of labeling; placement, form, and contents of statement of quantity; supplemental statement of quantity

§ 1454 - Rules and regulations

§ 1455 - Procedure for promulgation of regulations

USC : Title 18 - CRIMES AND CRIMINAL PROCEDURE

§ 1905 - Disclosure of confidential information generally

USC : Title 21 - FOOD AND DRUGS

§ 321 - Definitions; generally

§ 331 - Prohibited acts

§ 351 - Adulterated drugs and devices

§ 352 - Misbranded drugs and devices

§ 355 - New drugs

§ 360 - Registration of producers of drugs or devices

§ 360b - New animal drugs

§ 360c - Classification of devices intended for human use

§ 360d - Performance standards

§ 360e - Premarket approval

21 USC § 360e–1 - Pediatric uses of devices

§ 360f - Banned devices

§ 360g - Judicial review

§ 360h - Notification and other remedies

§ 360i - Records and reports on devices

§ 360j - General provisions respecting control of devices intended for human use

21 USC § -

§ 360m - Accredited persons

§ 371 - Regulations and hearings

§ 374 - Inspection

§ 381 - Imports and exports

§ 382 - Exports of certain unapproved products

§ 383 - Office of International Relations

§ 393 - Food and Drug Administration

U.S.C. : Title 42 - THE PUBLIC HEALTH AND WELFARE

§ 216 - Regulations

§ 241 - Research and investigations generally

42 USC § -

§ 262 - Regulation of biological products

§ 264 - Regulations to control communicable diseases

§ 265 - Suspension of entries and imports from designated places to prevent spread of communicable diseases